powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1619421450
Victoria Mock
M.D.
Pulmonary Disease
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
442
Unique beneficiaries
—
Total services
630
Distinct HCPCS
12
Medicare payment
$53K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 811 Pulmonary Disease providers in NY — below median (cohort median 790).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,554
Beneficiaries
—
Total drug cost
$335K
Distinct drugs
23
Brand share
65.2%
Top prescribed drugs
Albuterol Sulfate
377 claims
Fluticasone Propionate
144 claims
Montelukast Sodium
138 claims
Umeclidinium Brm/Vilanterol Tr
95 claims
Fluticasone/Umeclidin/Vilanter
91 claims